Free Newsletter
COO: Dr. Reddy's is looking for partners in Japan
A Dr. Reddy's Laboratories spokesman says the Indian drugmaker is in talks to enter Japan's generics market. "Yes, we are looking at Japan and we are looking for partnerships," Dr Reddy's, Managing Director and COO Satish Reddy told reporters at a conference. According to a report on ET Now television, Dr. Reddy's is in talks with three Japanese drugmakers to buy a stake. In identified the three companies as Towa Pharmaceutical, Sawai Pharmaceutical and Fuji Pharma. However, the three companies all denied the report, Bloomberg notes. Article | Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: